Eur Respir J 2003; 21:1050-1068
Copyright ©ERS Journals Ltd 2003
Indirect airway challenges
G.F. Joos and
B. O'Connor on behalf of the Task Force, Co-authors of the Task Force Report: G.F. Joos (Chairman), B. O'Connor (Co-Chairman), S.D. Anderson, F. Chung, D.W. Cockcroft, B. Dahlén, G. DiMaria, A. Foresi, F.E. Hargreave, S.T. Holgate, M. Inman, J. Lötvall, H. Magnussen, R. Polosa, D.S. Postma, J. Riedler
CORRESPONDENCE: G.F. Joos, Dept Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B-9000, Ghent, Belgium. Fax: 32 92402341. E-mail: guy.joos@rug.ac.be
Keywords: adenosine, asthma, bronchoprovocation, chronic obstructive pulmonary disease, exercise, methacholine
Received: February 24, 2003
Accepted
Abstract
Indirect challenges act by causing the release of endogenous mediators that cause the airway smooth muscle to contract. This is in contrast to the direct challenges where agonists such as methacholine or histamine cause airflow limitation predominantly via a direct effect on airway smooth muscle.
Direct airway challenges have been used widely and are well standardised. They are highly sensitive, but not specific to asthma and can be used to exclude current asthma in a clinic population. Indirect bronchial stimuli, in particular exercise, hyperventilation, hypertonic aerosols, as well as adenosine, may reflect more directly the ongoing airway inflammation and are therefore more specific to identify active asthma. They are increasingly used to evaluate the prevalence of bronchial hyperresponsiveness and to assess specific problems in patients with known asthma, e.g. exercise-induced bronchoconstriction, evaluation before scuba diving.
Direct bronchial responsiveness is only slowly and to a modest extent, influenced by repeated administration of inhaled steroids. Indirect challenges may reflect more closely acute changes in airway inflammation and a change in responsiveness to an indirect stimulus may be a clinically relevant marker to assess the clinical course of asthma. Moreover, some of the indirect challenges, e.g. hypertonic saline and mannitol, can be combined with the assessment of inflammatory cells by induction of sputum.
This article has been cited by other articles:

|
 |

|
 |
 
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
59 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Derom, R. Louis, C. Tiesler, R. Engelstatter, J-M. Kaufman, and G. F. Joos
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma
Eur. Respir. J.,
June 1, 2009;
33(6):
1277 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Hallstrand, E. Y. Chi, A. G. Singer, M. H. Gelb, and W. R. Henderson Jr.
Secreted Phospholipase A2 Group X Overexpression in Asthma and Bronchial Hyperresponsiveness
Am. J. Respir. Crit. Care Med.,
December 1, 2007;
176(11):
1072 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sivasankar and K. V. Fisher
Vocal Fold Epithelial Response to Luminal Osmotic Perturbation
J Speech Lang Hear Res,
August 1, 2007;
50(4):
886 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carlsten, M. L. Aitken, and T. S. Hallstrand
Safety of Sputum Induction With Hypertonic Saline Solution in Exercise-Induced Bronchoconstriction
Chest,
May 1, 2007;
131(5):
1339 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Prieto, I. Reig, R. Rojas, A. Ferrer, and J. Domenech
The effect of challenge method on sensitivity and reactivity to adenosine 5'-monophosphate in subjects with suspected asthma.
Chest,
November 1, 2006;
130(5):
1448 - 1453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ihre, P. Gyllfors, L. E. Gustafsson, M. Kumlin, and B. Dahlen
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Eur. Respir. J.,
June 1, 2006;
27(6):
1152 - 1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J W Dickinson, G P Whyte, A K McConnell, M G Harries, and K W Rundell
Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods * Commentary
Br. J. Sports Med.,
February 1, 2006;
40(2):
179 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yoo, J. Yu, D. K. Kim, S. H. Choi, C. K. Kim, and Y. Y. Koh
Methacholine and adenosine 5'-monophosphate challenges in children with post-infectious bronchiolitis obliterans
Eur. Respir. J.,
January 1, 2006;
27(1):
36 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. O. Koskela, K. M. Kontra, M. K. Purokivi, and J. T. Randell
Interpretation of Cough Provoked by Airway Challenges
Chest,
November 1, 2005;
128(5):
3329 - 3335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Verges, G. Devouassoux, P. Flore, E. Rossini, M. Fior-Gozlan, P. Levy, and B. Wuyam
Bronchial Hyperresponsiveness, Airway Inflammation, and Airflow Limitation in Endurance Athletes
Chest,
June 1, 2005;
127(6):
1935 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Nielsen and H. Bisgaard
Hyperventilation with Cold versus Dry Air in 2- to 5-Year-Old Children with Asthma
Am. J. Respir. Crit. Care Med.,
February 1, 2005;
171(3):
238 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Prieto, C. Badiola, J. Cortijo, C. Perez-Frances, V. Gutierrez, and A. Lanuza
Phenol-Containing Saline Solution as a Diluent for Adenosine 5'-Monophosphate in Bronchial Challenge Testing
Chest,
January 1, 2005;
127(1):
125 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J-W.J. Lammers
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
Eur. Respir. J.,
April 1, 2004;
23(4):
559 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Grootendorst and K. F. Rabe
Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2004;
1(2):
77 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Holgate, J. Holloway, S. Wilson, F. Bucchieri, S. Puddicombe, and D. E. Davies
Epithelial-Mesenchymal Communication in the Pathogenesis of Chronic Asthma
Proceedings of the ATS,
April 1, 2004;
1(2):
93 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Delvaux, M Henket, L Lau, P Kange, P Bartsch, R Djukanovic, and R Louis
Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma
Thorax,
February 1, 2004;
59(2):
111 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the European Respiratory Society.
|